$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Blood substitutes 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-037/14
  • C07K-013/00
출원번호 US-0194338 (1988-05-16)
우선권정보 GB-0011614 (1987-05-16)
발명자 / 주소
  • Hoffman Stephen L. (Denver CO) Nagai Kiyoshi (Cambridge GB2)
출원인 / 주소
  • Somatogenetics International, Inc. (Broomfield CO 02)
인용정보 피인용 횟수 : 99  인용 특허 : 1

초록

Solutions of mutant hemoglobins having a lower oxygen affinity than that of native hemoglobin are used as blood substitutes. The mutant hemoglobins are preferably obtained by recombinant DNA techniques. Both alpha and beta globin chains can now be so prepared, making possible the production of wholl

대표청구항

A method of supplementing the oxygen-carrying capacity of a patient\s blood which comprises administering to the patient a nontoxic composition comprising a cell-free mutant hemoglobin.

이 특허에 인용된 특허 (1)

  1. Tye Ross W. (937 B Rosenstock Rd. Sausalito CA 94965), Modified crosslinked stroma-free tetrameric hemoglobin.

이 특허를 인용한 특허 (99)

  1. Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  2. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  3. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  4. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  5. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis J.; Fraser, Richard; Harris, Stanley; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  6. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis J.; Fraser, Richard; Harris, Stanley; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  7. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis; Fraser, Richard; Harris, Stanley; Schein, Douglas, Apparatus and method for maintaining and/or restoring viability of organs.
  8. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Schein, Douglas; Harris, Stanley; Steibel, Dennis; Fraser, Richard; Isaacs, Dickon, Apparatus and method for maintaining and/or restoring viability of organs.
  9. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Schein, Douglas; Isaacs, Dickon, Apparatus and method for maintaining and/or restoring viability of organs.
  10. Fronticelli,Clara; Brinigar,William S., Blood substitutes.
  11. Donald R. Owen, Brain resuscitation apparatus and method.
  12. Tye,Ross Walden, Carboxymethylated cross-linked tetrameric hemoglobin.
  13. Winslow, Robert M.; Vandegriff, Kim D., Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  14. Winslow, Robert M.; Vandegriff, Kim D., Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  15. Anderson David C. ; Mathews Antony James ; Stetler Gary L., DNA for the production of multimeric hemoglobins.
  16. Wright, David Walter; Garland, Jeffrey C., Device for separating gas from a liquid path.
  17. Morrow Robert E., Electrically hydrolyzed salines as microbicides.
  18. Morrow Robert E. (Salt Lake City UT), Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species.
  19. Olson, John S.; Weiss, Mitchell J., Enhancing recombinant hemoglobin production by co-expression with alpha hemoglobin stabilizing protein.
  20. De Angelo Joseph ; Motwani Nalini M. ; Bajwa Wajeeh ; Bonaventura Joseph, Expression of recombinant hemoglobin and hemoglobin variants in yeast.
  21. Anthony-Cahill Spencer J. ; Epp Janet K. ; Kerwin Bruce A. ; Olins Peter O. ; Mathews Antony J.,NZX, Globins containing binding domains.
  22. Tsyrlova Irena ; Wolpe Stephen D., Hemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferation.
  23. Tsyrlova Irena ; Wolpe Stephen D., Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation.
  24. Tsyrlova, Irena; Wolpe, Stephen D., Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation.
  25. Olson John S. ; Whitaker Timothy L. ; Hargrove Mark S., Hemoglobin mutants that reduce heme loss.
  26. Olson, John S.; Whitaker, Timothy L.; Hargrove, Mark S., Hemoglobin mutants that reduce heme loss.
  27. Michael J. Weickert ; Christopher B. Glascock ; Antony J. Mathews NZ; Douglas D. Lemon ; Daniel H. Doherty ; John S. Olson, Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging.
  28. Weickert,Michael J; Glascock,Christopher B; Mathews,Antony J; Lemon,Douglas D; Doherty,Daniel H; Olson,John S, Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging.
  29. Anderson David C. (San Bruno CA) Mathews Antony James (Louisville CO), Hemoglobins as drug delivery agents.
  30. Anderson David C. ; Mathews Antony James, Hemoglobins as drug delivery agents.
  31. Hoffman Stephen J. ; Nagai Kiyoshi,GB2, Hemoglobins with intersubunit disulfide bonds.
  32. Olson, John S.; Phillips, Jr., George N., Increasing the stability of recombinant adult human apohemoglobin.
  33. Wolpe, Stephen D.; Tsyrlova, Irena, Inhibitor and stimulator of stem cell proliferation and uses thereof.
  34. Kozlov Vladimir,RUX ; Tsyrlova Irena, Inhibitor of stem cell proliferation and uses thereof.
  35. Tsyrlova, Irena; Wolfe, Stephen D., Inhibitor of stem cell proliferation and uses thereof.
  36. Vladimir Kozlov RU; Irena Tsyrlova, Inhibitor of stem cell proliferation and uses thereof.
  37. Wolpe Stephen D., Inhibitor of stem cell proliferation and uses thereof.
  38. Chien Ho ; Ching-Hsuan Tsai ; Tsuei-Yun Fang TW; Tong-Jian Shen, Low oxygen affinity mutant hemoglobins.
  39. Ho, Chien; Tsai, Ching-Hsuan; Fang, Tsuei-Yun; Shen, Tong-Jian, Low oxygen affinity mutant hemoglobins.
  40. Ho, Chien; Tsai, Ching-Hsuan; Fang, Tsuei-Yun; Shen, Tong-Jian, Low oxygen affinity mutant hemoglobins.
  41. Ho, Chien; Tsai, Ching-Hsuan; Fang, Tsuei-Yun; Shen, Tong-Jian, Low oxygen affinity mutant hemoglobins.
  42. Marbán, Eduardo; Li, Tao-Sheng, Maintenance of genomic stability in cultured stem cells.
  43. Wright, David Walter; Schein, Douglas; Brassil, John, Method and apparatus for controlling air pressure in an organ or tissue container.
  44. Wright, David Walter; Schein, Douglas; Brassil, John, Method and apparatus for controlling air pressure in an organ or tissue container.
  45. Schein, Douglas; Travis, Lee William, Method and apparatus for holding a plurality of tubes connectible to an organ or tissue container.
  46. Garland, Jeffrey C.; Schein, Douglas; Wright, David Walter, Method and apparatus for transferring heat to or from an organ or tissue container.
  47. Garland, Jeffrey C; Schein, Douglas; Wright, David Walters, Method and apparatus for transferring heat to or from an organ or tissue container.
  48. Kerwin Bruce A., Method for control of functionality during cross-linking of hemoglobins.
  49. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis J.; Fraser, Richard; Harris, Stanley; Schein, Douglas, Method for controlling perfusion of an organ.
  50. Fischer James J. ; Baserga Susan J., Method for increasing tissue oxygenation using fish hemoglobin exhibiting a root effect.
  51. Winslow, Robert M.; Vandegriff, Kim D., Method for making a high oxygen affinity modified hemoglobin for oxygen transport.
  52. Looker Douglas L. ; Stetler Gary L., Method of determining a functional linker for fusing globin subunts.
  53. Brassil, John; Schein, Douglas; Curtis, Christopher, Method of determining that an organ is not suitable for transplantation and using it for testing substances.
  54. Owen, Donald R.; Kravitz, David C.; Brassil, John; Brockbank, Kelvin G. M.; Burroughs, Andrew; Isaacs, Dickon; Steibel, Dennis J; Fraser, Richard; Harris, Stanley; Schein, Douglas; Curtis, Christopher G., Method of determining transport and/or storage parameters for maintaining viability of an organ.
  55. Bolton Anthony E. (Sheffield GB2), Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human.
  56. Oberholzer, Jose; Doubleday, Marc, Method of isolating cells from a tissue in a mammal.
  57. Shorr Robert G. L., Method of reducing side effects associated with administration of oxygen-carrying proteins.
  58. Rosenthal Gary J. (Boulder CO) Gerber Michael J. (Denver CO), Method of stimulating hematopoiesis with hemoglobin.
  59. Owen, Donald R.; Kravitz, David C., Method of transporting and storing a kidney.
  60. Bolton, Anthony E., Method of treating atherosclerosis.
  61. Winslow, Robert M.; Vandegriff, Kim D., Method to enhance hemodynamic stability using oxygen carrying compositions.
  62. Robert M. Winslow, Methods and compositions for optimization of oxygen transport by cell-free systems.
  63. Winslow Robert M., Methods and compositions for optimization of oxygen transport by cell-free systems.
  64. Winslow,Robert M., Methods and compositions for optimization of oxygen transport by cell-free systems.
  65. Winslow,Robert M.; Vandegriff,Kim D., Methods and compositions for oxygen transport comprising modified hemoglobin in plasma.
  66. Dewhirst Mark W. (Chapel Hill NC) Meyer Robert E. (Cary NC) Bonaventura Joseph (Beauford NC) DeAngelo Joseph (Hamtramck MI), Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders.
  67. Dewhirst Mark W. (Chapel Hill NC) Meyer Robert E. (Cary NC) Bonaventura Joseph (Beaufort NC) DeAngelo Joseph (Hamtramck MI), Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders.
  68. Dewhirst Mark W. ; Meyer Robert E. ; Bonaventura Joseph ; DeAngelo Joseph, Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders.
  69. Dewhirst Mark W. ; Meyer Robert E. ; Bonaventura Joseph ; DeAngelo Joseph, Methods for improving therapeutic effectiveness of treatment of vascularization disorders.
  70. Winslow, Robert M.; Vandegriff, Kim D., Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin.
  71. Simoni, Jan S.; Simoni, Grace; Feola, Mario J., Methods of treating acute blood loss.
  72. Cooper, Christopher Eric; Wilson, Michael Thomas; Reeder, Brandon Jon, Modified globin proteins with altered electron transport pathway.
  73. Lalezari Iraj ; Lalezari Parviz, Modified hemoglobin and its use as a component of an artificial blood substitute.
  74. Trimble Stephen P. ; Mathews Antony J. ; Kerwin Bruce A. ; Marquardt David A. ; Anthony-Cahill Spencer ; Epp Janet K. ; Madril Dominic G. ; Anderson David C., Modified hemoglobin-like compounds and methods of purifying same.
  75. Camiener Gerald W., Modified porphyroproteins.
  76. Olson John S. ; Mathews Antony J. ; Aitken Jacqueline F.,NZX ; Nagai Kyoshi,GBX, Mutant recombinant hemoglobins containing heme pocket mutations.
  77. Tye, Ross Walden, Nitric oxide-blocked cross-linked tetrameric hemoglobin.
  78. Tye,Ross Walden, Nitric oxide-blocked cross-linked tetrameric hemoglobin.
  79. Tye, Ross Walden, Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin.
  80. Olson John S. ; Mathews Antony J. ; Aitken Jacqueline F.,NZX ; Nagai Kyoshi,GBX, Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations.
  81. Sligar Stephen G. ; Sanders Kevin, Oxygen-binding heme proteins incorporating circularly-permuted globins.
  82. Fronticelli, Clara, Polymeric hemoglobin mutants.
  83. Avella,Anthony; DeWoskin,Richard; Doubleday,Marc, Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing.
  84. Avella,Anthony; DeWoskin,Richard; Doubleday,Marc, Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing.
  85. Hoffman Stephen J. (Cherry Hills Village CO) Nagai Kiyoshi (Cambridge GB2), Polynucleotides encoding genetically engineered mutant hemoglobins.
  86. Anderson David C. (San Bruno CA) Mathews Antony J. (Louisville CO) Stetler Gary L. (Boulder CO), Production and use of multimeric hemoglobins.
  87. Anderson David C. ; Mathews Antony J. ; Stetler Gary L., Production and use of multimeric hemoglobins.
  88. Kumar Ramesh ; Sharma Ajay ; Paulhiac Clara ; Khoury-Christianson Anastasia P. ; Midha Sunita, Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids.
  89. Looker, Douglas L.; Apostol, Izydor Z.; Brucker, Eric A.; Doyle, Michael P.; Foster, David L.; Glascock, Christopher B.; Hartman, James C.; Lee, Geoffrey F.; Lemon, Douglas D.; Moore, Edwin G.; Richa, Reduced side-effect hemoglobin compositions.
  90. Looker,Douglas L.; Apostol,Izydor Z.; Brucker,Eric A.; Doyle,Michael P.; Foster,David L.; Glascock,Christopher B.; Hartman,James C.; Lee,Geoffrey F.; Lemon,Douglas D.; Moore,Edwin G.; Richards,Jane P, Reduced side-effect hemoglobin compositions.
  91. Gerber Michael J. ; Looker Douglas L. ; Kerwin Bruce A., Stabilized compositions containing hemoglobin.
  92. Gerber Michael J. ; Looker Douglas L. ; Kerwin Bruce A., Stabilized compositions containing hemoglobin.
  93. Wolpe,Stephen D.; Tsyrlova,Irena, Stimulator of stem cell division.
  94. Welch William D. ; Robinson Daniel L., System for carrying out sterilization of equipment.
  95. Welch William D. ; Robinson Daniel L., System for elctrolyzing fluids for use as antimicrobial agents.
  96. Townes Tim M. (Birmingham AL) McCune Steven L. (Birmingham AL), Transgenic, cross-linked hemoglobin.
  97. Townes Tim M. ; McCune Steven L., Transgenic,cross-linked hemoglobin.
  98. Bolton, Anthony E., Treatment of autoimmune diseases.
  99. Zheleva,Daniella I.; Fischer,Peter Martin; McInnes,Campbell; Andrews,Martin J. I.; Chan,Weng C.; Atkinson,Gail E., p21 peptides.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로